{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:55:20Z","timestamp":1782921320380,"version":"3.54.5"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00496","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T13:05:38Z","timestamp":1557234338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["The Efflux Mechanism of Fraxetin-O-Glucuronides in UGT1A9-Transfected HeLa Cells: Identification of Multidrug Resistance-Associated Proteins 3 and 4 (MRP3\/4) as the Important Contributors"],"prefix":"10.3389","volume":"10","author":[{"given":"Zifei","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1517\/17425255.2014.952630","article-title":"Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.","volume":"10","author":"Bruhn","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1021\/acs.jafc.6b01580","article-title":"Phenolics from durian exert pronounced NO inhibitory and antioxidant activities.","volume":"64","author":"Feng","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1124\/dmd.106.014191","article-title":"Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms.","volume":"35","author":"Fujiwara","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091983","article-title":"In vitro glucuronidation of wushanicaritin by liver microsomes, intestine microsomes and expressed human UDP-glucuronosyltransferase enzymes.","volume":"18","author":"Hong","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development.","volume":"9","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"B6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1124\/dmd.111.041467","article-title":"UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP.","volume":"40","author":"Jiang","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.indcrop.2016.10.010","article-title":"Validated method for quality assessment of henna (Lawsonia inermis L.) leaves after postharvest blanching and its cosmetic application.","volume":"95","author":"Jyotshna","year":"2017","journal-title":"Ind. Crops Prod."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.intimp.2006.02.010","article-title":"Fraxetin inhibits the induction of anti-Fas IgM, tumor necrosis factor-\u03b1 and interleukin-1\u03b2-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63.","volume":"6","author":"Kuo","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/sj.clpt.6100073","article-title":"The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.","volume":"81","author":"L\u00e9vesque","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1021\/acs.jnatprod.6b00484","article-title":"\u03b1-Glucosidase and \u03b1-amylase inhibitors from Arcytophyllum thymifolium.","volume":"79","author":"Milella","year":"2016","journal-title":"J. Nat. Prod."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.biochi.2013.06.013","article-title":"Antihyperglycemic effect of fraxetin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats.","volume":"95","author":"Murali","year":"2013","journal-title":"Biochimie"},{"key":"B12","doi-asserted-by":"publisher","first-page":"G1493","DOI":"10.1152\/ajpgi.1999.276.6.G1493","article-title":"MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte.","volume":"276","author":"Ortiz","year":"1999","journal-title":"Am. J. Physiol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166239","article-title":"Regioselective glucuronidation of diosmetin and chrysoeriol by the interplay of glucuronidation and transport in UGT1A9-overexpressing HeLa cells.","volume":"11","author":"Passi","year":"2016","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1039\/c7fo01298e","article-title":"Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.","volume":"9","author":"Qin","year":"","journal-title":"Food Funct."},{"key":"B15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jpba.2018.03.047","article-title":"Metabolic profiling of corylin in vivo and in vitro.","volume":"155","author":"Qin","year":"","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1124\/dmd.114.061598","article-title":"Characterization of chrysin glucuronidation in UGT1A1-overexpressing HeLa cells: elucidating the transporters responsible for efflux of glucuronide.","volume":"43","author":"Quan","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"B17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tips.2008.01.006","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4): a versatile efflux transporter for drugs and signalling molecules.","volume":"29","author":"Russel","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1093\/jxb\/ery005","article-title":"Scopoletin 8-hydroxylase: a novel enzyme involved in coumarin biosynthesis and iron-deficiency responses in Arabidopsis.","volume":"69","author":"Siwinska","year":"2018","journal-title":"J. Exp. Bot."},{"key":"B19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1021\/acs.molpharmaceut.6b00754","article-title":"Inhibition of breast cancer resistance protein and multidrug resistance associated protein 2 by natural compounds and their derivatives.","volume":"14","author":"Sj\u00f6stedt","year":"2016","journal-title":"Mol. Pharm."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1021\/acs.jafc.5b00983","article-title":"Decreased expression of multidrug resistance-associated protein 4 (MRP4\/ABCC4) leads to reduced glucuronidation of flavonoids in UGT1A1-overexpressing HeLa cells: the role of futile recycling.","volume":"63","author":"Sun","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/tpj.2014.74","article-title":"Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.","volume":"15","author":"Tanaka","year":"2014","journal-title":"Pharmacogenomics J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1002\/anie.201300841","article-title":"Identification of cystathionine \u03b2-synthase inhibitors using a hydrogen sulfide selective probe.","volume":"52","author":"Thorson","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B23","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1124\/mol.108.052019","article-title":"Intestinal breast cancer resistance protein (BCRP)\/Bcrp1 and multidrug resistance protein 3 (MRP3)\/Mrp3 are involved in the pharmacokinetics of resveratrol.","volume":"75","author":"Van de Wetering","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jchromb.2016.02.030","article-title":"Simultaneous determination of fraxin and its metabolite, fraxetin, in rat plasma by liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.","volume":"101","author":"Wang","year":"2016","journal-title":"J Chromatogr. B"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/mnfr.201500321","article-title":"Establishment and use of new MDCK II cells overexpressing both UGT1A1 and MRP2 to characterize flavonoid metabolism via the glucuronidation pathway.","volume":"60","author":"Wang","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.3892\/mmr.2014.2529","article-title":"Antibacterial mechanism of fraxetin against Staphylococcus aureus.","volume":"10","author":"Wang","year":"2014","journal-title":"Mol. Med. Report."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.3934","article-title":"Comparative pharmacokinetic study of the main components of cortex fraxini after oral administration in normal and hyperuricemic rats.","volume":"31","author":"Wang","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1021\/mp300562q","article-title":"Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cells.","volume":"10","author":"Wei","year":"2013","journal-title":"Mol. Pharm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1007\/s11095-012-0817-2","article-title":"A new strategy to rapidly evaluate kinetics of glucuronide efflux by breast cancer resistance protein (BCRP\/ABCG2).","volume":"29","author":"Wu","year":"2012","journal-title":"Pharm. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1002\/jps.22568","article-title":"First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.","volume":"100","author":"Wu","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2133\/dmpk.DMPK-13-RG-059","article-title":"Identification and characterization of human UDP-glucuronosyltransferases responsible for the glucuronidation of fraxetin.","volume":"29","author":"Xia","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.phrs.2017.05.001","article-title":"UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: a systematic review of UGT isoforms for precision medicine.","volume":"121","author":"Yang","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1139\/cjpp-2017-0612","article-title":"Coumarins improved type 2 diabetes induced by high-fat diet and streptozotocin in mice via antioxidation.","volume":"96","author":"Yao","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"52661","DOI":"10.1039\/c7ra10376j","article-title":"Characterization of human UDP-glucuronosyltransferases responsible for glucuronidation and inhibition of norbakuchinic acid, a primary metabolite of hepatotoxicity and nephrotoxicity component bakuchiol in Psoralea corylifolia L.","volume":"7","author":"Yao","year":"2017","journal-title":"RSC Adv."},{"key":"B35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1021\/np0580412","article-title":"Metabolic fate of fraxin administered orally to rats.","volume":"69","author":"Yasuda","year":"2006","journal-title":"J. Nat. Prod."},{"key":"B36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/jpet.106.101840","article-title":"Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat.","volume":"319","author":"Zamek-Gliszczynski","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1124\/dmd.111.040162","article-title":"Efflux transport is an important determinant of ethinylestradiol glucuronide and ethinylestradiol sulfate pharmacokinetics.","volume":"39","author":"Zamek-Gliszczynski","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"B38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.vph.2016.09.002","article-title":"Antiplatelet activity of flavonoid and coumarin drugs.","volume":"87","author":"Zaragoza","year":"2016","journal-title":"Vascul. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T13:05:40Z","timestamp":1557234340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":38,"alternative-id":["10.3389\/fphar.2019.00496"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00496","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"article-number":"496"}}